MINAR1

Across TCGA pan-cancer cohorts, MINAR1 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of MINAR1’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where MINAR1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MINAR1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

LUAD, BLCA, and COAD are the cancer types where MINAR1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MINAR1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	All	+0.636	<.001	9	view →
BLCA	All	All	+0.532	.001	9	view →
COAD	Female	II,III,IV	+0.390	<.001	9	view →
LUSC	Male	All	+0.697	<.001	8	view →
HNSC	Female	III,IV	+0.635	.005	8	view →
BRCA	All	II,III,IV	+0.596	<.001	6	view →
STAD	Male	II,III,IV	+0.613	<.001	5	view →
UCEC	All	All	+0.450	.004	4	view →
KIRP	Female	II,III,IV	+0.496	<.001	3	view →
READ	All	III,IV	+0.375	.001	3	view →
CHOL	All	All	+0.847	.001	2	view →
LIHC	All	All	+0.109	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

MINAR1–LUAD

Open the LUAD breakdown →